Dual GIP and GLP-1 receptor agonist widely used in incretin-pathway research.
Triple GIP, GLP-1, and glucagon receptor agonist studied in metabolic and energy-balance research.
Long-acting GLP-1 receptor agonist analogue used in metabolic signalling studies.
Long-acting amylin analogue investigated alongside incretin agonists in satiety research.